Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium

Toxicology and Applied Pharmacology

Volumn 291, Issue , 2016, Pages 13-20

  Cooper, Karen L ^a   Dashner, Erica J ^a   Tsosie, Ranalda ^b   Cho, Young Mi ^c   Lewis, Johnnye ^a   Hudson, Laurie G ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c Hanyang University   (South Korea)

Author keywords

DNA damage; DNA repair; Poly(ADP ribose) polymerase 1 (PARP 1); Uranium; Zinc finger

Indexed keywords

HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; URANIUM; URANYL ACETATE; ZINC FINGER PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PARP1 PROTEIN, HUMAN;

ARTICLE; CELL DENSITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HEK293 CELL LINE; HUMAN; HUMAN CELL; IC50; JURKAT CELL LINE; KERATINOCYTE; KIDNEY CELL; PROTEIN FUNCTION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

CELL SURVIVAL; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HUMANS; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; POLY(ADP-RIBOSE) POLYMERASES; URANIUM;

EID: 84949908665     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.11.017     Document Type: Article

References (58)

1. Au W.W., Lane R.G., Legator M.S., Whorton E.B., Wilkinson G.S., Gabehart G.J. Biomarker monitoring of a population residing near uranium mining activities. Environ. Health Perspect. 1995, 103:466-470.
2. Au W.W., McConnell M.A., Wilkinson G.S., Ramanujam V.M., Alcock N. Population monitoring: experience with residents exposed to uranium mining/milling waste. Mutat. Res. 1998, 405:237-245.
3. Au W.W., Giri A.K., Ruchirawat M. Challenge assay: a functional biomarker for exposure-induced DNA repair deficiency and for risk of cancer. Int. J. Hyg. Environ. Health 2010, 213:32-39.
4. Bal W., Protas A.M., Kasprzak K.S. Genotoxicity of metal ions: chemical insights. Met. Ions Life Sci. 2011, 8:319-373.
5. Beyersmann D., Hartwig A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch. Toxicol. 2008, 82:493-512.
6. Briner W. The toxicity of depleted uranium. Int. J. Environ. Res. Public Health 2010, 7:303-313.
7. Brugge D., Buchner V. Health effects of uranium: new research findings. Rev. Environ. Health 2011, 26:231-249.
8. Brugge D., de Lemos J.L., Oldmixon B. Exposure pathways and health effects associated with chemical and radiological toxicity of natural uranium: a review. Rev. Environ. Health 2005, 20:177-193.
9. Burns F.J., Uddin A.N., Wu F., Nadas A., Rossman T.G. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ. Health Perspect. 2004, 112:599-603.
10. Cooper K.L., King B.S., Sandoval M.M., Liu K.J., Hudson L.G. Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc. Toxicol. Appl. Pharmacol. 2013, 269:81-88.
11. Coryell V.H., Stearns D.M. Molecular analysis of hprt mutations generated in Chinese hamster ovary EM9 cells by uranyl acetate, by hydrogen peroxide, and spontaneously. Mol. Carcinog. 2006, 45:60-72.
12. Craft E., Abu-Qare A., Flaherty M., Garofolo M., Rincavage H., Abou-Donia M. Depleted and natural uranium: chemistry and toxicological effects. J. Toxicol. Environ. Health B Crit. Rev. 2004, 7:297-317.
13. Dantzer F., Santoro R. The expanding role of PARPs in the establishment and maintenance of heterochromatin. FEBS J 2013, 280:3508-3518.
14. Darolles C., Broggio D., Feugier A., Frelon S., Dublineau I., De Meo M., Petitot F. Different genotoxic profiles between depleted and enriched uranium. Toxicol. Lett. 2010, 192:337-348.
15. Dedieu A., Berenguer F., Basset C., Prat O., Quemeneur E., Pible O., Vidaud C. Identification of uranyl binding proteins from human kidney-2 cell extracts by immobilized uranyl affinity chromatography and mass spectrometry. J. Chromatogr. A 2009, 1216:5365-5376.
16. deLemos J.L., Brugge D., Cajero M., Downs M., Durant J.L., George C.M., Henio-Adeky S., Nez T., Manning T., Rock T., Seschillie B., Shuey C., Lewis J. Development of risk maps to minimize uranium exposures in the Navajo Churchrock mining district. Environ. Heal. 2009, 8:29.
17. Ding W., Liu W., Cooper K.L., Qin X.J., de Souza Bergo P.L., Hudson L.G., Liu K.J. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem. 2009, 284:6809-6817.
18. Garmash S.A., Smirnova V.S., Karp O.E., Usacheva A.M., Berezhnov A.V., Ivanov V.E., Chernikov A.V., Bruskov V.I., Gudkov S.V. Pro-oxidative, genotoxic and cytotoxic properties of uranyl ions. J. Environ. Radioact. 2014, 127:163-170.
19. George S.A., Whittaker A.M., Stearns D.M. Photoactivated uranyl ion produces single strand breaks in plasmid DNA. Chem. Res. Toxicol. 2011, 24:1830-1832.
20. Gibson B.A., Kraus W.L. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell Biol. 2012, 13:411-424.
21. Guimaraes A.C., Antunes L.M., Ribeiro H.F., dos Santos A.K., Cardoso P.C., de Lima P.L., Seabra A.D., Pontes T.B., Pessoa C., de Moraes M.O., Cavalcanti B.C., Sombra C.M., Bahia Mde O., Burbano R.R. Cytogenetic biomonitoring of inhabitants of a large uranium mineralization area: the municipalities of Monte Alegre, Prainha, and Alenquer, in the State of Para, Brazil. Cell Biol. Toxicol. 2010, 26:403-419.
22. Hao Y., Ren J., Liu C., Li H., Liu J., Yang Z., Li R., Su Y. Zinc protects human kidney cells from depleted uranium-induced apoptosis. Basic Clin. Pharmacol. Toxicol. 2014, 114:271-280.
23. Hartsock W.J., Cohen J.D., Segal D.J. Uranyl acetate as a direct inhibitor of DNA-binding proteins. Chem. Res. Toxicol. 2007, 20:784-789.
24. Hartwig A. Metal interaction with redox regulation: an integrating concept in metal carcinogenesis?. Free Radic. Biol. Med. 2013, 55:63-72.
25. Heintze E., Aguilera C., Davis M., Fricker A., Li Q., Martinez J., Gage M.J. Toxicity of depleted uranium complexes is independent of p53 activity. J. Inorg. Biochem. 2011, 105:142-148.
26. Huang H., Chaudhary S., Van Horn J.D. Uranyl-peptide interactions in carbonate solution with DAHK and derivatives. Inorg. Chem. 2005, 44:813-815.
27. Hudson L.G., Cooper K.L., Atlas S.R., King B.K., Liu K.J. Arsenic interaction with zinc finger motifs. Arsenic: Exposure Sources, Health Risks and Mechanisms of Toxicity 2015, 291-314. Wiley & Sons, Inc. J.C. States (Ed.).
28. Hund L., Bedrick E., Miller C., Huerta G., Nez T., Ramone S., Shuey C., Cajero M., Lewis J. A Bayesian framework for estimating disease risk due to exposure to uranium mine and mill waste on the Navajo Nation. J. R. Stat. Soc. Ser. A (Stat. Soc.) 2015.
29. Knobel Y., Glei M., Weise A., Osswald K., Schaferhenrich A., Richter K.K., Claussen U., Pool-Zobel B.L. Uranyl nitrilotriacetate, a stabilized salt of uranium, is genotoxic in nontransformed human colon cells and in the human colon adenoma cell line LT97. Toxicol. Sci. 2006, 93:286-297.
30. Langelier M.F., Pascal J.M. PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis. Curr. Opin. Struct. Biol. 2013, 23:134-143.
31. Lewis J.L. DiNEH Project Update: Survey→Clinic→Mechanisms. USEPA Stakeholder Workshop 2013 http://www.epa.gov/region9/superfund/navajo-nation/pdf/stakeholder/2013/dr-lewis-di-neh-project-update2013.pdf.
32. Liu X., Palma J., Kinders R., Shi Y., Donawho C., Ellis P.A., Rodriguez L.E., Colon-Lopez M., Saltarelli M., LeBlond D., Lin C.T., Frost D.J., Luo Y., Giranda V.L. An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors. Anal. Biochem. 2008, 381:240-247.
33. Lourenco J., Pereira R., Pinto F., Caetano T., Silva A., Carvalheiro T., Guimaraes A., Goncalves F., Paiva A., Mendo S. Biomonitoring a human population inhabiting nearby a deactivated uranium mine. Toxicology 2013, 305:89-98.
34. Lu-Fritts P.Y., Kottyan L.C., James J.A., Xie C., Buckholz J.M., Pinney S.M., Harley J.B. Association of systemic lupus erythematosus with uranium exposure in a community living near a uranium-processing plant: a nested case-control study. Arthritis Rheum. 2014, 66:3105-3112.
35. Maret W. New perspectives of zinc coordination environments in proteins. J. Inorg. Biochem. 2012, 111:110-116.
36. Milgram S., Carriere M., Thiebault C., Malaval L., Gouget B. Cytotoxic and phenotypic effects of uranium and lead on osteoblastic cells are highly dependent on metal speciation. Toxicology 2008, 250:62-69.
37. Miller A.C., McClain D. A review of depleted uranium biological effects: in vitro and in vivo studies. Rev. Environ. Health 2007, 22:75-89.
38. Orona N.S., Tasat D.R. Uranyl nitrate-exposed rat alveolar macrophages cell death: influence of superoxide anion and TNF alpha mediators. Toxicol. Appl. Pharmacol. 2012, 261:309-316.
39. Periyakaruppan A., Kumar F., Sarkar S., Sharma C.S., Ramesh G.T. Uranium induces oxidative stress in lung epithelial cells. Arch. Toxicol. 2007, 81:389-395.
40. Periyakaruppan A., Sarkar S., Ravichandran P., Sadanandan B., Sharma C.S., Ramesh V., Hall J.C., Thomas R., Wilson B.L., Ramesh G.T. Uranium induces apoptosis in lung epithelial cells. Arch. Toxicol. 2009, 83:595-600.
41. Piatek K., Schwerdtle T., Hartwig A., Bal W. Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition. Chem. Res. Toxicol. 2008, 21:600-606.
42. Popp W., Plappert U., Muller W.U., Rehn B., Schneider J., Braun A., Bauer P.C., Vahrenholz C., Presek P., Brauksiepe A., Enderle G., Wust T., Bruch J., Fliedner T.M., Konietzko N., Streffer C., Woitowitz H.J., Norpoth K. Biomarkers of genetic damage and inflammation in blood and bronchoalveolar lavage fluid among former German uranium miners: a pilot study. Radiat. Environ. Biophys. 2000, 39:275-282.
43. Prabhavathi P.A., Fatima S.K., Rao M.S., Reddy P.P. Analysis of chromosomal aberration frequencies in the peripheral blood lymphocytes of smokers exposed to uranyl compounds. Mutat. Res. 2000, 466:37-41.
44. Qin X.J., Hudson L.G., Liu W., Timmins G.S., Liu K.J. Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity. Toxicol. Appl. Pharmacol. 2008, 232:41-50.
45. Rossman T.G., Uddin A.N., Burns F.J. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol. Appl. Pharmacol. 2004, 198:394-404.
46. Rouas C., Bensoussan H., Suhard D., Tessier C., Grandcolas L., Rebiere F., Dublineau I., Taouis M., Pallardy M., Lestaevel P., Gueguen Y. Distribution of soluble uranium in the nuclear cell compartment at subtoxic concentrations. Chem. Res. Toxicol. 2010, 23:1883-1889.
47. Stearns D.M., Yazzie M., Bradley A.S., Coryell V.H., Shelley J.T., Ashby A., Asplund C.S., Lantz R.C. Uranyl acetate induces hprt mutations and uranium-DNA adducts in Chinese hamster ovary EM9 cells. Mutagenesis 2005, 20:417-423.
48. Sun X., Zhou X., Du L., Liu W., Liu Y., Hudson L.G., Liu K.J. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicol. Appl. Pharmacol. 2014, 274:313-318.
49. Thiebault C., Carriere M., Milgram S., Simon A., Avoscan L., Gouget B. Uranium induces apoptosis and is genotoxic to normal rat kidney (NRK-52E) proximal cells. Toxicol. Sci. 2007, 98:479-487.
50. USEPA, 1995. Extraction and beneficiation of ores and minerals. Volume 5, Uranium. In Waste, O.o.S., (Ed.). USEPA Office of Solid Waste, Washington, DC.
51. USEPA, 2008a. Technical report on technologically enhanced naturally occurring radioactive materials from uranium mining. Volume 1: Mining and Reclaimation Background. In Air, O.o.R.a.I., (Ed.). USEPA, Washington, DC.
52. USEPA, 2008b. Technical report on technologically enhanced naturally occurring radioactive materials from uranium mining. Volume 2: Investigation of Potential Health, Geographic, and Environmental Issues of Abandoned Uranium Mines In Air, O.o.R.a.I., (Ed.). USEPA, Washington, DC.
53. Wagner S.E., Burch J.B., Bottai M., Pinney S.M., Puett R., Porter D., Vena J.E., Hebert J.R. Hypertension and hematologic parameters in a community near a uranium processing facility. Environ. Res. 2010, 110:786-797.
54. Wilson J., Young A., Civitello E.R., Stearns D.M. Analysis of heat-labile sites generated by reactions of depleted uranium and ascorbate in plasmid DNA. J. Biol. Inorg. Chem. 2014, 19:45-57.
55. Wilson J., Zuniga M.C., Yazzie F., Stearns D.M. Synergistic cytotoxicity and DNA strand breaks in cells and plasmid DNA exposed to uranyl acetate and ultraviolet radiation. J. Appl. Toxicol. 2015, 35:338-349.
56. Witkiewicz-Kucharczyk A., Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol. Lett. 2006, 162:29-42.
57. Zhou X., Sun X., Cooper K.L., Wang F., Liu K.J., Hudson L.G. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J. Biol. Chem. 2011, 286:22855-22863.
58. Zhou X., Sun X., Mobarak C., Gandolfi A.J., Burchiel S.W., Hudson L.G., Liu K.J. Differential binding of monomethylarsonous acid compared to arsenite and arsenic trioxide with zinc finger peptides and proteins. Chem. Res. Toxicol. 2014, 27:690-698.